• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.78% Nasdaq Down 1.13%

    More On CLDN

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Celladon Corporation (CLDN)

    -NasdaqGM
    1.15 0.00(0.00%) Mar 22, 3:58PM EDT
    Prev Close:1.15
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:3.00
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.86 - 25.49
    Volume:0
    Avg Vol (3m):160,282
    Market Cap:27.55M
    P/E (ttm):N/A
    EPS (ttm):-2.15
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CLDN

    Comparison

    Symbol% ChgMkt Cap
    CLDN 0.00%27.55M
    ABIODown 0.97%37.17M
    GSKDown 0.35%104.40B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celladon Corporation, a clinical-stage biotechnology company, focuses on developing cardiovascular gene therapy and calcium dysregulation. The company’s lead product candidate includes MYDICAR that uses genetic enzyme replacement therapy to c... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback